BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,256,000 | +4.2% | 4,107,000 | +7.1% | 0.12% | 0.0% |
| Q2 2018 | $4,085,000 | +23.1% | 3,834,000 | +18.6% | 0.12% | +5.4% |
| Q1 2018 | $3,319,000 | +16.3% | 3,234,000 | +22.8% | 0.11% | +15.5% |
| Q4 2017 | $2,854,000 | +79.5% | 2,634,000 | +85.0% | 0.10% | +70.2% |
| Q3 2017 | $1,590,000 | +0.1% | 1,424,000 | 0.0% | 0.06% | -5.0% |
| Q2 2017 | $1,588,000 | -2.0% | 1,424,000 | 0.0% | 0.06% | -3.2% |
| Q1 2017 | $1,621,000 | +0.7% | 1,424,000 | 0.0% | 0.06% | +3.3% |
| Q4 2016 | $1,610,000 | -6.0% | 1,424,000 | -0.3% | 0.06% | -1.6% |
| Q3 2016 | $1,712,000 | +1.5% | 1,428,000 | -5.7% | 0.06% | 0.0% |
| Q2 2016 | $1,687,000 | -3.7% | 1,515,000 | 0.0% | 0.06% | +7.0% |
| Q1 2016 | $1,752,000 | -4.7% | 1,515,000 | +5.8% | 0.06% | -5.0% |
| Q4 2015 | $1,839,000 | -7.0% | 1,432,000 | -5.4% | 0.06% | +3.4% |
| Q3 2015 | $1,978,000 | -12.3% | 1,514,000 | +4.5% | 0.06% | +1.8% |
| Q2 2015 | $2,256,000 | -24.5% | 1,449,000 | -28.7% | 0.06% | -24.0% |
| Q1 2015 | $2,989,000 | +24.6% | 2,031,000 | -0.0% | 0.08% | +29.3% |
| Q4 2014 | $2,399,000 | +11.2% | 2,032,000 | 0.0% | 0.06% | +5.5% |
| Q3 2014 | $2,157,000 | -35.5% | 2,032,000 | -37.1% | 0.06% | -32.1% |
| Q2 2014 | $3,345,000 | -39.3% | 3,232,000 | -35.7% | 0.08% | -40.0% |
| Q1 2014 | $5,508,000 | +1.0% | 5,024,000 | -1.8% | 0.14% | -4.9% |
| Q4 2013 | $5,452,000 | – | 5,115,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|